Life Molecular Imaging SA clinical trials
Acquired by Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
The registry lists 12 studies whose lead sponsor is Life Molecular Imaging SA. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.
Before and after it joined Lantheus Holdings, Inc.
- First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- 12
- First submitted after Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Life Molecular Imaging SA10 studies
- Life Molecular Imaging GmbH2 studies
Something wrong with this grouping? Tell us on the Lantheus Holdings, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 12 of 12. All Lantheus Holdings, Inc. studies →
- Test-retest Study With [18F]PI-2620 in PSP-RS and NDCCompletedNCT05187546Phase 1
Sponsor listed in the registry: Life Molecular Imaging GmbH · First submitted before Life Molecular Imaging GmbH became part of Lantheus Holdings, Inc.
- Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific ActivityCompletedNCT04715750Phase 1
Sponsor listed in the registry: Life Molecular Imaging GmbH · First submitted before Life Molecular Imaging GmbH became part of Lantheus Holdings, Inc.
- Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain InjuryTerminatedNCT05337774Phase 1
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate CancerTerminatedNCT02483884Phase 1/2
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- PET Imaging of Intracranial Cancers With 18F-FSPGTerminatedNCT02370563Phase 1
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyCompletedNCT01020838Phase 3
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- Exploration of Tumor Accumulation of BAY94-9392 in Patients With CancerCompletedNCT01186601Phase 1
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersCompletedNCT00750282Phase 2
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.CompletedNCT00928304Phase 2
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy VolunteersCompletedNCT01205321Phase 1
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy VolunteersCompletedNCT01153607Phase 1
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.
- PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.CompletedNCT01297088Phase 1
Sponsor listed in the registry: Life Molecular Imaging SA · First submitted before Life Molecular Imaging SA became part of Lantheus Holdings, Inc.